A.K.T. Huusom

659 total citations
9 papers, 521 citations indexed

About

A.K.T. Huusom is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Biological Psychiatry. According to data from OpenAlex, A.K.T. Huusom has authored 9 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Experimental and Cognitive Psychology and 2 papers in Biological Psychiatry. Recurrent topics in A.K.T. Huusom's work include Treatment of Major Depression (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Mental Health Research Topics (5 papers). A.K.T. Huusom is often cited by papers focused on Treatment of Major Depression (8 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Mental Health Research Topics (5 papers). A.K.T. Huusom collaborates with scholars based in Denmark, United Kingdom and France. A.K.T. Huusom's co-authors include David S. Baldwin, Ioana Florea, J. Bothmer, Stuart Montgomery, Christer Allgulander, Ian Hindmarch, James A. Cooper, Tine A. Bækdal, Marco Sarchiapone and J.P. Boulenger and has published in prestigious journals such as The British Journal of Psychiatry, The International Journal of Neuropsychopharmacology and European Neuropsychopharmacology.

In The Last Decade

A.K.T. Huusom

9 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.K.T. Huusom Denmark 7 379 314 180 80 71 9 521
P. Tanghøj Denmark 11 313 0.8× 156 0.5× 285 1.6× 97 1.2× 69 1.0× 18 653
J. Massana Spain 8 219 0.6× 151 0.5× 135 0.8× 83 1.0× 58 0.8× 9 392
Angelo Sambunaris United States 10 324 0.9× 140 0.4× 200 1.1× 39 0.5× 81 1.1× 15 436
Charles Merideth United States 10 234 0.6× 195 0.6× 335 1.9× 95 1.2× 49 0.7× 11 607
Ira Fox United States 8 281 0.7× 189 0.6× 192 1.1× 63 0.8× 27 0.4× 8 443
P. M. Manniche Denmark 7 219 0.6× 217 0.7× 157 0.9× 118 1.5× 25 0.4× 11 400
C. Lewis Ravaris United States 11 205 0.5× 205 0.7× 196 1.1× 103 1.3× 65 0.9× 15 501
Aleksandar Skuban United States 12 576 1.5× 137 0.4× 616 3.4× 85 1.1× 92 1.3× 18 854
Katja Wiethoff Germany 9 169 0.4× 119 0.4× 126 0.7× 46 0.6× 65 0.9× 17 335
William Rekshan Singapore 11 240 0.6× 278 0.9× 113 0.6× 47 0.6× 94 1.3× 13 543

Countries citing papers authored by A.K.T. Huusom

Since Specialization
Citations

This map shows the geographic impact of A.K.T. Huusom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.K.T. Huusom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.K.T. Huusom more than expected).

Fields of papers citing papers by A.K.T. Huusom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.K.T. Huusom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.K.T. Huusom. The network helps show where A.K.T. Huusom may publish in the future.

Co-authorship network of co-authors of A.K.T. Huusom

This figure shows the co-authorship network connecting the top 25 collaborators of A.K.T. Huusom. A scholar is included among the top collaborators of A.K.T. Huusom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.K.T. Huusom. A.K.T. Huusom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Boulenger, J.P., et al.. (2010). Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine. Current Medical Research and Opinion. 26(3). 605–614. 15 indexed citations
2.
Pihl, Susanne, et al.. (2010). Evaluation of An Isochronic Study Design for Long-Term Frozen Stability Investigation of Drugs in Biological Matrices. Bioanalysis. 2(6). 1041–1049. 7 indexed citations
3.
Huusom, A.K.T., et al.. (2006). A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Current Medical Research and Opinion. 22(7). 1331–1341. 89 indexed citations
4.
Baldwin, David S., et al.. (2006). Escitalopram and paroxetine in the treatment of generalised anxiety disorder. The British Journal of Psychiatry. 189(3). 264–272. 86 indexed citations
5.
Baldwin, David S., James A. Cooper, A.K.T. Huusom, & Ian Hindmarch. (2006). A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. International Clinical Psychopharmacology. 21(3). 159–169. 82 indexed citations
6.
Allgulander, Christer, Ioana Florea, & A.K.T. Huusom. (2005). Prevention of relapse in generalized anxiety disorder by escitalopram treatment. The International Journal of Neuropsychopharmacology. 9(5). 495–495. 96 indexed citations
7.
Montgomery, Stuart, A.K.T. Huusom, & J. Bothmer. (2004). A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder. Neuropsychobiology. 50(1). 57–64. 138 indexed citations
8.
Baldwin, David S., et al.. (2004). P.3.019 Escitalopram and paroxetine compared toplacebo in the treatment of of Generalised Anxiety Disorder (GAD). European Neuropsychopharmacology. 14. S311–S312. 6 indexed citations
9.
Montgomery, S.A., A.K.T. Huusom, & J. Bothmer. (2002). Escitalopram is a new and highly efficacious SSRI in the treatment of major depressive disorder. European Neuropsychopharmacology. 12. 254–255. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026